Lewis Williams Net Worth & Insider Trades
Lewis Williams - Director, Five Prime Therapeutics, Inc
What is Lewis Williams's Net Worth?
The current estimated net worth of Five Prime Therapeutics, Inc's Director, Lewis Williams, is estimated to be about $112.9M . Lewis Williams owns about 433,892 units of Five Prime Therapeutics, Inc common stock. In the last 4 years at Five Prime Therapeutics, Inc, Lewis Williams has sold an estimated value of $18M worth.
What is Lewis Williams's Past Insider Trading?
Lewis Williams's largest purchase order was 52,801 units , worth over $448.28K on April 7, 2016. Lewis Williams's largest sale order was 71,229 units , worth over $2.38M on February 8, 2016. In total, Lewis Williams has made about 33 transactions over 4 years of their time at Five Prime Therapeutics, Inc. Lewis Williams usually trades in September and February, with the busiest year in 2016. The most recent transaction was a sale order of 30,000 units , worth over $1.51M on December 23, 2016.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lewis Williams
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Lewis Williams's' Mailing Address?
- Mailing address is C/o Five Prime Therapeutics, Inc. Two Corporate Drive South San Francisco CA 94080 CA
What are Five Prime Therapeutics, Inc's Past Insider Trades?
Five Prime Therapeutics, Inc's most recent insider trade came on November 13, 2020 by Pil Partners Bvf, Fund Value Biotechnology, Bvf I GP Llc, Biotechnology Value Fund Ii Lp, Bvf Ii GP Llc, Biotechnology Value Trading Fund Os Lp, Bvf Partners Os Ltd, Bvf GP Holdings Llc, Incil Bvf and Mark Lampert who sold 7,393,340 units worth $149.25M . In the last 5 years, insiders at Five Prime Therapeutics, Inc have sold an estimated value of $191.93M and bought an estimated value of $25.9M worth of shares. Insider trading is most common in May, with the busiest year in 2016. The most active traders at the company are Marc Aron Knickerbocker, President & CEO, Lewis Williams, Director, and William Ringo, Director .
FIVE PRIME THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||